We are live on ! Find out more
DG

Delek Group Portfolio holdings

AUM $2.59B
1-Year Est. Return 1.24%
This Fund
S&P 500
This Quarter Est. Return
+12.46%
1 Year Est. Return
-1.24%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.41B
AUM Growth
+$213M
Cap. Flow
+$87.9M
Cap. Flow %
3.65%
Top 10 Hldgs %
23.02%
Holding
258
New
42
Increased
72
Reduced
68
Closed
52
Avg Time Held Equity + Options
3.2 quarters
Top 10 Avg Time Held Equity + Options
2.2 quarters
Top 20 Avg Time Held Equity + Options
3.4 quarters
Avg Time Held Equity only
3.2 quarters
Top 10 Avg Time Held Equity only
2.2 quarters
Top 20 Avg Time Held Equity only
3.4 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 18.57%
2 Technology 15.73%
3 Healthcare 14.58%
4 Energy 9.98%
5 Industrials 9.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CMMB icon
201
Chemomab Therapeutics
CMMB
$9.09M
$176K 0.01%
+408
New +$206K
2019 Q1
0 quarters
EOCN icon
202
Eocene Ltd. Ordinary Shares
EOCN
$3.39M
$173K 0.01%
+15
New +$174K
2019 Q1
0 quarters
INDP icon
203
Indaptus Therapeutics
INDP
$318M
$154K 0.01%
+9
New +$158K
2019 Q1
0 quarters
ARTX
204
DELISTED
Arotech Corporation
ARTX
$153K 0.01%
+52,398
New +$167K
2019 Q1
0 quarters
MDWD icon
205
MediWound
MDWD
$158M
$141K 0.01%
+4,058
New +$137K
2019 Q1
0 quarters
BLRX icon
206
BioLineRX
BLRX
$10.8M
$92K ﹤0.01%
+359
New +$105K
2019 Q1
0 quarters
ADBE icon
207
Adobe
ADBE
$92B
– –
-2,848
Closed -$684K –
AGO icon
208
Assured Guaranty
AGO
$3.06B
– –
-200,000
Closed -$7.86M –
AMZN icon
209
Amazon
AMZN
$2.79T
– –
-8,280
Closed -$663K –
BIIB icon
210
Biogen
BIIB
$33.8B
– –
-25,000
Closed -$7.72M –
BLUE icon
211
DELISTED
bluebird bio
BLUE
– –
-5,858
Closed -$7.73M –
CAMT icon
212
CALL
Camtek
CAMT
$6.66B
– –
-105,000
Closed -$711K –
CAMT icon
213
PUT
Camtek
CAMT
$6.66B
– –
-157,500
Closed -$1.07M –
OPPJ icon
214
WisdomTree Trust WisdomTree Japan Opportunities Fund
OPPJ
$336M
– –
-19,810
Closed -$378K –
EWA icon
215
PUT
iShares MSCI Australia ETF
EWA
$1.2B
– –
-10,000
Closed -$412K –
F icon
216
Ford
F
$48.2B
– –
-130,054
Closed -$1.08M –
FEZ icon
217
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.15B
– –
-8,660
Closed -$298K –
FLEX icon
218
Flex
FLEX
$41B
– –
-20,569
Closed -$121K –
GDX icon
219
VanEck Gold Miners ETF
GDX
$26.2B
– –
-49,291
Closed -$1.04M –
GE icon
220
GE Aerospace
GE
$319B
– –
-122,149
Closed -$4.55M –
HBAN icon
221
Huntington Bancshares
HBAN
$30.8B
– –
-550,000
Closed -$6.79M –
IFF icon
222
CALL
International Flavors & Fragrances
IFF
$22.5B
– –
-53,000
Closed -$7.12M –
IGV icon
223
iShares Expanded Tech-Software Sector ETF
IGV
$14.8B
– –
-10,700
Closed -$401K –
IJH icon
224
iShares Core S&P Mid-Cap ETF
IJH
$123B
– –
-6,065
Closed -$218K –
ITA icon
225
iShares US Aerospace & Defense ETF
ITA
$11.9B
– –
-5,240
Closed -$477K –

Similar funds

Delek Group's Q1 2019 Portfolio in Review

As of Q1 2019, Delek Group held 258 positions worth $2.41B, up 9.7% from $2.19B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Delek Group deployed $87.9M of net new capital in Q1 2019, opening 42 new positions and adding to 72 existing holdings. Its largest new stake was Owens Corning: 500,000 shares worth $23.5M.

By sector, the portfolio is most concentrated in Miscellaneous at 19% of assets, down from 22% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Micron Technology, an estimated $24.9M trimmed.

  • Delek Group's largest Q1 2019 buy was Owens Corning: 500,000 shares worth $23.5M.
  • Delek Group added most to Teva Pharmaceutical Industries Limited in Q1 2019, an estimated $30.9M increase.
  • Delek Group's biggest Q1 2019 reduction was Micron Technology, cutting an estimated $24.9M.
  • Delek Group fully exited SodaStream International Ltd in Q1 2019, selling an estimated $13.8M.
  • Delek Group's ten largest holdings make up 23% of its $2.41B portfolio in Q1 2019.
  • Delek Group opened 42 new positions and closed 52 in Q1 2019.
  • Delek Group's portfolio value rose 9.7% quarter-over-quarter to $2.41B.

Based on Delek Group's 13F filing for Q1 2019, filed 13 May 2019.